


In a joint recent study of 2017 the VDMA Large Industrial Plant Manufacturers' Group and MaexPartners analyzed the potential of Industry 4.0 for large industrial plant manufacturing.


















Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active pharmaceutical ingredients (APIs) and finished drug products.













